Jiangsu Kanion Pharmaceutical Co.,Ltd. Sustainability Profile
Jiangsu Kanion Pharmaceutical Co., Ltd., a prominent player in the pharmaceutical industry, is headquartered in China (CN) and operates extensively across various regions. Founded in 1995, the company has established itself as a leader in the development and manufacturing of high-quality pharmaceutical products, including traditional Chinese medicine and modern pharmaceuticals. With a commitment to innovation, Kanion has achieved significant milestones, including the development of unique formulations that blend traditional practices with modern science. Their core offerings, which encompass a range of therapeutic areas, are distinguished by their efficacy and safety, catering to both domestic and international markets. Recognised for its robust market position, Jiangsu Kanion Pharmaceutical continues to expand its influence, contributing to advancements in healthcare and setting benchmarks in quality and reliability within the industry.
DitchCarbon Score
How does Jiangsu Kanion Pharmaceutical Co.,Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Jiangsu Kanion Pharmaceutical Co.,Ltd.'s score of 22 is lower than 76% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Jiangsu Kanion Pharmaceutical Co.,Ltd.'s reported carbon emissions
Jiangsu Kanion Pharmaceutical Co., Ltd., headquartered in China (CN), currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Furthermore, the company has not established any documented reduction targets or climate pledges, which suggests a lack of formal commitments towards reducing its carbon footprint. As of now, Jiangsu Kanion Pharmaceutical Co., Ltd. does not inherit emissions data from any parent or related organizations, indicating that its climate impact assessment is independent. Without available data or commitments, the company’s position in the context of industry climate initiatives remains unclear. In summary, Jiangsu Kanion Pharmaceutical Co., Ltd. has not disclosed any emissions data or climate commitments, reflecting a potential area for future development in sustainability practices within the pharmaceutical sector.
How Carbon Intensive is Jiangsu Kanion Pharmaceutical Co.,Ltd.'s Industry?
How Carbon Intensive is Jiangsu Kanion Pharmaceutical Co.,Ltd.'s Location?
Jiangsu Kanion Pharmaceutical Co.,Ltd.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Jiangsu Kanion Pharmaceutical Co.,Ltd. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
